Mr. Greenberg, Director of Analysis Group’s Health Care Practice, specializes in health economics, both in health outcomes research and in complex business litigation. He has overseen cost-of-illness research relating to numerous physical and psychiatric disorders, as well as pharmacoeconomic assessments of the cost-effectiveness of drugs based on data gathered in clinical trials and administrative claims files. Mr. Greenberg’s health outcomes research has been published in leading medical, health economics, and managed care journals.
